Below The Threshold, Not Above The Law: FTC Cracks Down On HSR Avoidance

The FTC secured a record $12 million penalty against Edwards Lifesciences and Genesis MedTech for structuring a medical device acquisition to avoid Hart-Scott-Rodino premerger reporting requirements. This signals aggressive enforcement against deal structuring designed to stay below HSR thresholds, particularly in concentrated sectors like medical devices.

This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.